These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29393182)

  • 1. Chemotherapy of Diffuse Astrocytoma (WHO grade II) in Adults.
    Narita Y
    Prog Neurol Surg; 2018; 31():145-151. PubMed ID: 29393182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Role of Chemotherapy in the Treatment of Low-grade Gliomas].
    Lakomý R; Kazda T; Poprach A; Pospíšil P; Jančálek R; Šlampa P
    Klin Onkol; 2017; 30(5):343-348. PubMed ID: 29031036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When temozolomide alone fails: adding procarbazine in salvage therapy of glioma.
    Huang F; Kavan P; Guiot MC; Markovic Y; Roberge D
    Can J Neurol Sci; 2008 May; 35(2):192-7. PubMed ID: 18574933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
    Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
    J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH-Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA Cohort.
    Esteyrie V; Dehais C; Martin E; Carpentier C; Uro-Coste E; Figarella-Branger D; Bronniman C; Pouessel D; Ciron DL; Ducray F; Moyal EC; Network P
    Oncologist; 2021 May; 26(5):e838-e846. PubMed ID: 33524191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade glioma.
    van den Bent MJ
    Neuro Oncol; 2014 Dec; 16(12):1570-4. PubMed ID: 25355680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas.
    Newlands ES; Foster T; Zaknoen S
    Br J Cancer; 2003 Jul; 89(2):248-51. PubMed ID: 12865911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade glioma in children and adolescents: a single-center experience.
    Yazici G; Zorlu F; Cengiz M; Ozyigit G; Eren G; Yüce D; Varan A; Akyuz C; Akalan N; Gurkaynak M
    Childs Nerv Syst; 2016 Feb; 32(2):291-7. PubMed ID: 26679932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of chemotherapy in the treatment of low-grade glioma. A review of the literature.
    Neyns B; Sadones J; Chaskis C; De Ridder M; Keyaerts M; Veld PI; Michotte A
    Acta Neurol Belg; 2005 Sep; 105(3):137-43. PubMed ID: 16255151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
    Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1147-52. PubMed ID: 15001257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen?
    Lassman AB
    CNS Oncol; 2015; 4(5):341-6. PubMed ID: 26544062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
    Levin VA
    Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-grade gliomas.
    Schiff D
    Continuum (Minneap Minn); 2015 Apr; 21(2 Neuro-oncology):345-54. PubMed ID: 25837900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404.
    Prados MD; Scott C; Sandler H; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1109-15. PubMed ID: 10613302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide.
    Strowd RE; Abuali I; Ye X; Lu Y; Grossman SA
    J Neurooncol; 2016 Mar; 127(1):165-71. PubMed ID: 26729269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of Oligodendrogliomas.
    Drappatz J; Lieberman F
    Prog Neurol Surg; 2018; 31():152-161. PubMed ID: 29393183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-grade and anaplastic oligodendroglioma.
    Van Den Bent MJ; Bromberg JE; Buckner J
    Handb Clin Neurol; 2016; 134():361-80. PubMed ID: 26948366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of temozolomide resistance in low-grade gliomas using a mechanistic mathematical model.
    Ollier E; Mazzocco P; Ricard D; Kaloshi G; Idbaih A; Alentorn A; Psimaras D; Honnorat J; Delattre JY; Grenier E; Ducray F; Samson A
    Fundam Clin Pharmacol; 2017 Jun; 31(3):347-358. PubMed ID: 27933657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy in low-grade gliomas.
    Viaccoz A; Lekoubou A; Ducray F
    Curr Opin Oncol; 2012 Nov; 24(6):694-701. PubMed ID: 22913972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial.
    Medical Research Council Brain Tumor Working Party
    J Clin Oncol; 2001 Jan; 19(2):509-18. PubMed ID: 11208845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.